Form 4: STAAR Surgical: Officer Sells Shares to Cover Taxes
Insider Transaction Report
STAAR Surgical Co. reports a transaction where Chief Development Officer Magda Michna sold shares to cover tax obligations.
Summary
- Magda Michna, Chief Development Officer at STAAR Surgical Co. (STAA), reported a transaction on May 8, 2026.
- The transaction involved the sale of 1,680 shares of common stock at a price of $26.69 per share.
- These shares were withheld to satisfy tax obligations related to restricted stock units (RSUs).
- Following this transaction, Michna beneficially owns 32,691 shares of common stock.
- This filing also includes a correction to a previously misreported number of owned securities, adjusting the count from 29,668 to 29,688.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it reports a routine insider transaction for tax purposes rather than a strategic decision impacting company valuation.
Positives
- The transaction addresses tax liabilities, which is a standard and necessary corporate action.
- The reporting person continues to hold a significant number of shares (32,691) after the transaction.
Negatives
- The sale of shares, even for tax purposes, represents a reduction in the reporting person's direct ownership.
Future Outlook
The filing does not contain forward-looking statements or guidance. It is a report of a past transaction.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those related to tax obligations or the exercise of stock options/RSUs, are common occurrences for executives in the medical device sector. These events are typically routine and do not necessarily indicate a change in management's outlook on the company's performance, though they are closely watched by investors.
Stakeholder Impact
- Shareholders: The transaction does not directly impact the company's overall financial health but reflects a standard component of executive compensation and tax management.
- Employees: No direct impact on other employees is indicated by this filing.
- Management: Reflects the operational aspects of executive compensation plans.
Key Dates
| Date | Description |
|---|---|
| 05/08/2023 | Grant date of restricted stock units (RSUs). |
| 05/08/2024 | First vesting date for 1/3 of RSUs. |
| 05/08/2025 | Second vesting date for 1/3 of RSUs. |
| 03/12/2026 | Date of original Form 4 filing with a misreported number of owned securities. |
| 05/08/2026 | Transaction date for the sale of shares to cover taxes and final vesting date for the remaining 1/3 of RSUs. |
| 05/12/2026 | Date of the current Form 4 filing. |
Keywords
STAAR SURGICAL CO, STAA, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Magda Michna, Chief Development Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.